Boston-based SpringLeaf (fka Entra Pharmaceuticals) also garnered backing in the round from previous Boston-area investors Flybridge Capital Partners and North Bridge Venture Partners, both of which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback